Search Results - "Tintu, Andrei N."

Retrospective Longitudinal Monitoring of Multiple Myeloma Patients by Mass Spectrometry Using Archived Serum Protein Electrophoresis Gels and De Novo Sequence Analysis by Noori, Somayya, Zajec, Marina, Russcher, Henk, Tintu, Andrei N., Broijl, Annemiek, Jacobs, Joannes F. M., Luider, Theo M., Rijke, Yolanda B., vanDuijn, Martijn M.

Get full text

Uterine Vascular Function in a Transgenic Preeclampsia Rat Model by Verlohren, Stefan, Niehoff, Manuela, Hering, Lydia, Geusens, Nele, Herse, Florian, Tintu, Andrei N, Plagemann, Andreas, LeNoble, Ferdinand, Pijnenborg, Robert, Muller, Dominik N, Luft, Friedrich C, Dudenhausen, Joachim W, Gollasch, Maik, Dechend, Ralf

“…We investigated intrauterine growth restriction, endothelial function, and uterine artery blood flow characteristics in a transgenic preeclampsia rat model…”
Get full text

Design of fork-join networks of First-In-First-Out and infinite-server queues applied to clinical chemistry laboratories by Tsai, Eline R., Demirtas, Derya, Tintu, Andrei N., de Jonge, Robert, de Rijke, Yolanda B., Boucherie, Richard J.

“…•Accurate queueing network capturing performance of real-world laboratory systems.•Centralized decision maker that optimizes static routes minimizing mean…”
Get full text

The influence of undetected hemolysis on POCT potassium results in the emergency department by Tintu, Andrei N, Buño Soto, Antonio, Van Hoof, Viviane, Bench, Suzanne, Malpass, Anthony, Schilling, Ulf Martin, Rooney, Kevin, Oliver Sáez, Paloma, Relker, Lasse, Luppa, Peter

“…This study aimed to evaluate discrepancies in potassium measurements between point-of-care testing (POCT) and central laboratory (CL) methods, focusing on the…”
Get more information

Failure Mode and Effects Analysis (FMEA) at the preanalytical phase for POCT blood gas analysis: proposal for a shared proactive risk analysis model by Van Hoof, Viviane, Bench, Suzanne, Soto, Antonio Buño, Luppa, Peter P, Malpass, Anthony, Schilling, Ulf Martin, Rooney, Kevin D, Stretton, Adam, Tintu, Andrei N

“…Proposal of a risk analysis model to diminish negative impact on patient care by preanalytical errors in blood gas analysis (BGA). Here we designed a Failure…”
Get more information

Diagnostic Accuracy of Portable, Handheld Point-of-Care Tests vs Laboratory-Based Bilirubin Quantification in Neonates: A Systematic Review and Meta-analysis by Westenberg, Lauren E H, Been, Jasper V, Willemsen, Sten P, Vis, Jolande Y, Tintu, Andrei N, Bramer, Wichor M, Dijk, Peter H, Steegers, Eric A P, Reiss, Irwin K M, Hulzebos, Christian V

“…Quantification of bilirubin in blood is essential for early diagnosis and timely treatment of neonatal hyperbilirubinemia. Handheld point-of-care (POC) devices…”
Get more information

A critical review of laboratory performance indicators by Tsai, Eline R., Tintu, Andrei N., Demirtas, Derya, Boucherie, Richard J., de Jonge, Robert, de Rijke, Yolanda B.

“…Healthcare budgets worldwide are under constant pressure to reduce costs while improving efficiency and quality. This phenomenon is also visible in clinical…”
Get full text

Added value of drug-laboratory test interaction alerts in test result authorisation by van Balveren, Jasmijn A, Verboeket-van de Venne, Wilhelmine P H G, Doggen, Carine J M, Erdem-Eraslan, Lale, de Graaf, Albert J, Krabbe, Johannes G, Musson, Ruben E A, Oosterhuis, Wytze P, de Rijke, Yolanda B, van der Sijs, Heleen, Tintu, Andrei N, Verheul, Rolf J, Hoedemakers, Rein M J, Kusters, Ron

Get more information

Characterization of Laboratory Flow and Performance for Process Improvements via Application of Process Mining by Tsai, Eline R, Tintu, Andrei N, Boucherie, Richard J, de Rijke, Yolanda B, Schotman, Hans H M, Demirtas, Derya

“…The rising level of laboratory automation provides an increasing number of logged events that can be used for the characterization of laboratory performance…”
Get full text

Real-time monitoring of drug laboratory test interactions: a proof of concept by van Balveren, Jasmijn A, Verboeket-van de Venne, Wilhelmine P H G, Doggen, Carine J M, Erdem-Eraslan, Lale, de Graaf, Albert J, Krabbe, Johannes G, Musson, Ruben E A, Oosterhuis, Wytze P, de Rijke, Yolanda B, van der Sijs, Heleen, Tintu, Andrei N, Verheul, Rolf J, Hoedemakers, Rein M J, Kusters, Ron

“…For the correct interpretation of test results, it is important to be aware of drug-laboratory test interactions (DLTIs). If DLTIs are not taken into account…”
Get more information

Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey by van Balveren, Jasmijn A, Verboeket-van de Venne, Wilhelmine P H G, Doggen, Carine J M, Cornelissen, Anne S, Erdem-Eraslan, Lale, de Graaf, Albert J, Krabbe, Johannes G, Musson, Ruben E A, Oosterhuis, Wytze P, de Rijke, Yolanda B, van der Sijs, Heleen, Tintu, Andrei N, Verheul, Rolf J, Hoedemakers, Rein M J, Kusters, Ron

“…Knowledge of possible drug-laboratory test interactions (DLTIs) is important for the interpretation of laboratory test results. Failure to recognize these…”
Get more information

Pre-implementation guidelines for infectious disease point-of-care testing in medical institutions by van der Eijk, Annemiek A, Tintu, Andrei N, Hays, John P

“…Infectious disease point-of-care test (ID-POCT) devices are becoming widely available, and in this respect, international quality standards and guidelines are…”
Get full text

Development and validation of an early warning model for hospitalized COVID-19 patients: a multi-center retrospective cohort study by Smit, Jim M., Krijthe, Jesse H., Tintu, Andrei N., Endeman, Henrik, Ludikhuize, Jeroen, van Genderen, Michel E., Hassan, Shermarke, El Moussaoui, Rachida, Westerweel, Peter E., Goekoop, Robbert J., Waverijn, Geeke, Verheijen, Tim, den Hollander, Jan G., de Boer, Mark G. J., Gommers, Diederik A. M. P. J., van der Vlies, Robin, Schellings, Mark, Carels, Regina A., van Nieuwkoop, Cees, Arbous, Sesmu M., van Bommel, Jasper, Knevel, Rachel, de Rijke, Yolanda B., Reinders, Marcel J. T.

“…Background Timely identification of deteriorating COVID-19 patients is needed to guide changes in clinical management and admission to intensive care units…”
Get full text